Project Grant HT94252410152
Award Date
3/1/24
Completion Date
2/28/27
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The University of Pittsburgh - Of the Commonwealth System of Higher Education (University of Pittsburgh) was awarded a $1,246,455 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to characterize a novel class of non-competitive androgen receptor antagonists from May 15, 2023 to May 14, 2026. The Military Medical Research and Development program aims to transform military and public health...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
The University of Pittsburgh - Of The Commonwealth System of Higher Education was awarded a $4,902,315 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project titled "Understanding the Effects of Intracavitary Conditioning in Breast Cancer Metastatic to the Pleura or the Peritoneum" with a performance period from June 1, 2025 to May 31, 2029. The research aims to...
The University of Pittsburgh was awarded a $925,680 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2027 targeting the IGFBP2-SRC signaling axis to block metastatic spread and tumor-mesothelial crosstalk. Through this research, the University aims to develop medical solutions for the battlefield by investigating approaches to prevent cancer metastasis. The Military...
This federal Project Grant award in the amount of $1,572,933.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is being used to fund research at the University of Pittsburgh aimed at targeting lysosomal pathways to improve host immunity following coronavirus infections. The research seeks to explore innovative approaches to disease prevention, diagnosis, treatment, and management of conditions relevant to military...
The University of Pittsburgh has been awarded a $1,541,823 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development federal grant program (CFDA 12.420) to develop fast treatment methods for metastatic cancer patients with pleural disease. The grant, which runs from November 1, 2024 to October 31, 2028, will fund the University's research efforts to explore innovative approaches to disease prevention, diagnosis, treatment, and management of these...
The University of Pittsburgh - Of The Commonwealth System of Higher Education was awarded a $1,148,334.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop viral delivery strategies for targeted hair cell regeneration. The award, which began on May 15, 2025 and has an ultimate completion date of May 14, 2028, supports advanced biomedical research initiatives focused on transforming healthcare for military service...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, was awarded a $636,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on a novel combination therapy targeting growth factor receptor cross talk with epitranscriptomic regulation in glioblastoma, a type of brain cancer, with the goal of developing innovative medical...